These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4361298)

  • 21. Experimental Diarrhoea in human volunteers following oral administration of Clostridium perfringens enterotoxin.
    Skjelkvåle R; Uemura T
    J Appl Bacteriol; 1977 Oct; 43(2):281-6. PubMed ID: 201601
    [No Abstract]   [Full Text] [Related]  

  • 22. A proposed sero-grouping scheme for epidemiological investigation of food poisoning due to Clostridium perfringens type A.
    Chakrabarty AK; Narayan KG
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):114-22. PubMed ID: 44603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro production of Clostridium perfringens enterotoxin and its detection by reversed passive hemagglutination.
    Uemura T; Sakaguchi G; Riemann HP
    Appl Microbiol; 1973 Sep; 26(3):381-5. PubMed ID: 4356461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of monoclonal antibodies to Clostridium perfringens enterotoxin.
    Horiguchi Y; Uemura T; Kamata Y; Kozaki S; Sakaguchi G
    Infect Immun; 1986 Apr; 52(1):31-5. PubMed ID: 2870028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A negative serological relationship between cases of grass sickness in Scotland and Clostridium perfringens type A enterotoxin.
    Gilmour JS; Brown R; Johnson P
    Equine Vet J; 1981 Jan; 13(1):56-8. PubMed ID: 6263613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological characteristics of Clostridium perfringens type A enterotoxin.
    Stark RL; Duncan CL
    Infect Immun; 1971 Aug; 4(2):89-96. PubMed ID: 4343403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Production of anti-enterotoxin antiserum to Clostridium perfringens type A toxin].
    Bakulin IN; Zemlianitskaia EP; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):111-2. PubMed ID: 6277108
    [No Abstract]   [Full Text] [Related]  

  • 28. A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.
    Mietzner TA; Kokai-Kun JF; Hanna PC; McClane BA
    Infect Immun; 1992 Sep; 60(9):3947-51. PubMed ID: 1500207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluid secretory response of bovine Thiry jejunal fistula to enterotoxin of Clostridium perfringens.
    Niilo L
    Infect Immun; 1973 Jan; 7(1):1-4. PubMed ID: 4347724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refractoriness of rabbit towards Clostridium perfringens type A enterotoxin.
    Chakrabarty AK; Narayan KG
    Indian J Exp Biol; 1978 Mar; 16(3):402-3. PubMed ID: 210117
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of biological activities of purified and crude enterotoxin of Clostridium perfringens.
    Nilo L
    Infect Immun; 1975 Aug; 12(2):440-2. PubMed ID: 168155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double antibody sandwich enzyme-immunoassay for Clostridium perfringens type A enterotoxin detection in stool specimens.
    Jackson SG; Yip-Chuck DA; Brodsky MH
    J Immunol Methods; 1985 Oct; 83(1):141-50. PubMed ID: 2865314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular antibody against Clostridium perfringens enterotoxin fails to counteract toxin-induced damage.
    Petrie HT; McDonel JL; Schlegel RA
    Cell Biol Int Rep; 1982 Jul; 6(7):705-11. PubMed ID: 6290086
    [No Abstract]   [Full Text] [Related]  

  • 34. Reverse phase passive haemagglutination and single radial immunodiffusion to detect epsilon antigen of Clostridium perfringens type D.
    Beh KJ; Buttery SH
    Aust Vet J; 1978 Nov; 54(11):541-4. PubMed ID: 223537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enterotoxigenic Clostridium perfringens type A isolated from intestinal contents of cattle, sheep and chickens.
    Niilo L
    Can J Comp Med; 1978 Jul; 42(3):357-63. PubMed ID: 210914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of Clostridium perfringens type A enterotoxin by electroimmunodiffusion.
    Duncan CL; Somers EB
    Appl Microbiol; 1972 Nov; 24(5):801-4. PubMed ID: 4344960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunochemical investigations on the antigenic structure of heat resistant "Cl. perfringens" type A strains.
    Meisel-Mikolajczyk F; Dworczyński A; Kubica J
    Prog Immunobiol Stand; 1970; 4():601-8. PubMed ID: 4320521
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and antibody responses to Clostridium perfringens type A enterotoxin in experimental sheep and calves.
    Niilo L; Cho HJ
    Can J Comp Med; 1985 Apr; 49(2):145-8. PubMed ID: 4016579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient increase in capillary permeability induced by Clostridium perfringens type A enterotoxin.
    Stark RL; Duncan CL
    Infect Immun; 1972 Jan; 5(1):147-50. PubMed ID: 4348076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of an indirect haemagglutination test for the detection of Clostridium perfringens type A enterotoxin.
    Serafim MB; Colli IA; Ricci LC; de Castro AF
    Mem Inst Oswaldo Cruz; 1991; 86(1):25-9. PubMed ID: 1842397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.